Tcell progenitors that develop in the thymus to mature T cells are submitted to a series of selective events (reviewed in reference [@B1]), the first of which takes place when immature CD4^−^CD8^−^CD3^−^ cells differentiate into CD4^+^ CD8^+^ double positive (DP)^1^ cells. A second selection occurs when DP thymocytes differentiate into CD4^+^ or CD8^+^ mature T cells, and is generally referred to as positive selection. It is well established that positive selection involves sustained interactions of the TCR αβ heterodimer with complexes of peptides and MHC antigens on thymic stromal cells (reviewed in references [@B2]--[@B4]). During this selection process, either CD4 or CD8 is downregulated. There is current debate over whether downregulation of CD4 or CD8, and thus commitment to CD4^+^ or CD8^+^ T cells, is dictated by the MHC specificity of the TCR (instructive model) ([@B5], [@B6]) or whether it occurs in a stochastic fashion independent of TCR/MHC interactions (selective model) ([@B7]--[@B9]). In the majority of the studies addressing the issue of positive selection, all CD3^high^ thymocytes with a CD4 or CD8 single positive (SP) phenotype were considered to have completed the process of positive selection and to be functionally mature. However, recent studies in the mouse indicate that not all SP thymocytes that have been submitted to positive selection signals are functionally mature. It is known that SP cells are phenotypically heterogeneous with respect to CD24 (heat stable antigen) and CD69 ([@B10], [@B11]). In addition, CD4^+^ SP thymocytes with intermediate levels of CD24 express very low levels of CD8 when analyzed with a sensitive panning method ([@B11]). More recently, it has been demonstrated that although the CD4^+^CD8^low^ cells had hallmarks of positive selection such as CD69 and high levels of TCR, they were not able to induce a lethal Graft versus host disease upon transfer into irradiated allogeneic recipients and to survive in the periphery ([@B12]). The immature CD3^high^CD4^+^CD8^low^ cells require the thymic environment to reach the end stage of positive selection ([@B12]). These data suggest that when functional immunocompetence of T cells is taken as the end stage of positive selection, this process is not necessarily completed when CD4 or CD8 are downregulated.

Here we report on the identification of downregulation of CD1a as a hallmark for functional maturation, not only of SP human thymocytes, but also of DP cells. To arrive at this model, we made use of the observations that DP cells contain in vitro clonogenic cells both in human ([@B13], [@B14]) and mouse ([@B15]). These observations were intriguing because if one accepts that maturity of T cells is appropriately reflected by their capacity to expand in vitro, some DP cells should have been submitted to a maturation signal. The presence of both mature clonogenic DP cells and immature CD4^+^ SP cells ([@B12]) is difficult to reconcile with a linear model of thymocyte differentiation from immature CD3^+^CD4^+^CD8^+^ DP via immature to mature SP cells. A possible explanation for the existence of both in vitro clonogenic mature DP thymocytes and presumably immature SP cells could be that there are bifurcations in the pathway of later stages of T cell development. The data presented here are consistent with this notion, since it was found that acquisition of functional maturity correlates perfectly with downregulation of CD1a and, most importantly, not with downregulation of CD4 or CD8. Moreover, we show here that MHC class II--positive, but not MHC class II--negative, mouse thymic microenvironments can support differentiation of human progenitors into CD3^+^CD4^+^ SP cells. However, human TCRαβ^+^ CD4^+^ SP cells selected on mouse MHC class II continue to express CD1a and exhibit poor clonogenic potential in vitro, suggesting that a species-specific signal is required for downregulation of CD1a and induction of functional maturity in the CD4 TCRαβ lineage.

Materials and Methods
=====================

Preparation and Phenotypic Analysis of Thymocyte Subpopulations.
----------------------------------------------------------------

Thymocyte tissues were obtained from children 3 mo--10 yr of age undergoing median sternotomy and corrective cardiovascular surgery. Suspensions were made by mincing tissue and pressing through a stainless steel mesh. Large aggregates were removed, and the cells were washed once before separating subpopulations.

To prepare CD34^+^ subpopulations, total thymocytes were first incubated with saturating concentrations of anti-CD4 (RPA-T4), anti-CD8 (RPA-T8) (provided by Dr. G. Aversa, DNAX Research Institute, Palo Alto, CA), anti-CD69 (Leu-23, gift of Dr. J.H. Phillips, DNAX Researach Institute), and anti-CD27 (gift of Dr. R. van Lier, Central Laboratory of the Blood Transfusion Service of the Netherlands Red Cross, Amsterdam, Netherlands). The labeled cells were removed by using magnetic beads coated with sheep anti--mouse immunoglobulins (Dynal Inc., Oslo, Norway) and a samarium cobalt magnet. The cells remaining after the first depletion were labeled with anti-CD56 (L185, from Dr. J.H. Phillips), anti-CD19, and anti-CD14 (CLB CD19 and CLB CD14, respectively, from Dr. R. van Lier) to remove the NK, B, and myeloid cells, and again subjected to depletion with magnetic beads. The enriched cells were incubated with antiCD34 FITC (HPCA-2 from Becton Dickinson, San Jose, CA) and anti-CD1a PE (T6-RD1 from Coulter Corp., Hialeah, FL). CD34^+^CD1a^−^ cells were sorted with a FACStar plus^®^. Purity of the cell populations was always \>98%.

Three-color analyses were performed with antibodies tagged with FITC, PE, or TriColor (TRC). In some experiments biotinylated antibodies that were revealed with avidin-CyCr were used as third antibody. Cytoplasmic staining with FITC-conjugated anti--Bcl-2 mAb (clone 124; DAKO A/S, Glostrup, Denmark) was performed as described previously ([@B16]). Three-color analysis was carried out on the FACScan^®^.

Limiting Dilution Assays.
-------------------------

CD1a^+^ and CD1a^−^ DP, CD4^+^ and CD8^+^ SP thymocytes were plated under limiting dilution conditions in 96-well round-bottomed wells. The thymocytes were cultured in the presence of 5.10^4^ irradiated (3.10^3^ rad) allogeneic PBMC and 5.10^3^ irradiated (5.10^3^ rad) EBV transformed B cells (JY) per well in 100 μl of culture medium supplemented with 0.1 μg/ml of PHA (Wellcome, Beckenham, Kent, UK) and 30 U/ml of recombinant IL-2 (Chiron Europe, Amsterdam, Netherlands). Culture medium consisted of Yssel\'s medium ([@B17]) supplemented with 2% human serum. After 5 d of culture, 100 μl fresh culture medium with 30 U/ml rIL-2 was added. Wells were screened microscopically for cell growth after 2--4 wk of culture.

Hybrid Human/Mouse Fetal Thymic Organ Cultures.
-----------------------------------------------

The in vitro development of human T and NK cells from CD34^+^ thymocytes was studied using the hybrid human/mouse fetal thymic organ culture (FTOC) in which human progenitor cells were cocultured with murine fetal thymuses ([@B18]). These thymuses were obtained from embryos of recombination activating gene (RAG)-1--deficient mice on days 15--16 of gestation. To investigate the role of murine MHC class II antigens in development of human cells, FTOC were set up with thymuses of MHC class II--deficient mice ([@B19]), provided by Dr. L. Glimcher (Harvard School of Public Health, Boston, MA).

The fetal thymuses were first precultured for 5 d in the presence of 1.35 mM 2-deoxyguanosine to remove endogenous thymocytes. Next, the thymic lobes were cocultured for 2 d in hanging drops in Terasaki wells with FACS^®^ sorted human progenitor cells, transferred to nucleopore filters which were layered over gelfoam rafts in 6-well plates, and cultured for the indicated number of days. Culture medium consisted of Yssel\'s medium supplemented with 2% normal human serum and 5% fetal calf serum. To analyze differentiation of human cells, the mouse thymuses were dispersed into single cell suspensions and stained with mAbs specific for human cell surface antigens.

Isolation of Stromal Cells.
---------------------------

Heterogeneous cell cultures of thymic stroma were obtained for mechanic disruption of the thymic parenchyma and enzymatic treatment with collagenase and lipase and enrichment for large adherent cells ([@B20], [@B21]). Adherent cells were cultured in RPMI-1640 (GIBCO BRL, Gaithersburg, MD) supplemented with 10% FCS. The cultures were washed each day during the first days of culture to remove any remaining thymocytes. Stromal cells were used after two or three passages.

RNA Isolation and cDNA Preparation.
-----------------------------------

Total RNA was isolated from sorted cells using the guanidine thiocyanate method ([@B22]). Glycogen (20 μg; Boehringer Mannheim, Indianapolis, IN) was added to each sample to facilitate precipitation of the RNA. The cDNA was prepared with oligo(dT)~15~ (PharMingen, San Diego, CA) and reversed transcribed with 200 U M-MLV reverse transcriptase (GIBCO BRL). Dilutions of the cDNA in water (5 ngeq RNA/μl) were used in PCR amplification reactions.

Semi-quantitative PCR.
----------------------

A semi-quantitative PCR method ([@B23], [@B24]) was used to compare the expression of RAG-1 in thymocyte subpopulations. Synthetic oligonucleotides (Pharmacia LKB Biotechnology Inc., Piscataway, NJ) used as primers are as follows: 5′-TATGGACAGGACTGAACGTCTTGC-3′ (hypoxanthine phosphoribosyl transferase \[HPRT\] sense), 5′-GACACAAACATGATTCAAATCCCTGA-3′ (HPRT antisense), 5′-GAACACACTTTGCCTTCTCTTTGG-3′ (RAG1 sense), 5′-CGCTTTGCCTCTTGCTTTCTCGTT-3′ (RAG1 antisense). Standard curves for HPRT and RAG-1 were set up using serial dilutions of cDNA prepared from RNA isolated from total thymus. Dilutions of cDNA samples in water were made starting with a concentration of 0.5 ngeq RNA/μl to determine HPRT expression and 5 ngeq RNA/μl to determine RAG-1 expression. PCR was carried out in a total volume of 50 μl consisting of 1 μM of each primer set, 200 μM each dNTP (Pharmacia LKB Biotechnology Inc.), 2.5 mM MgCl~2~, 1× PCR buffer, 1 U Taq DNA polymerase (GIBCO BRL), and 10 μl of the cDNA. Samples were covered with 50 μl paraffin oil and heated to 94°C for 5 min and then amplified for 30 cycles of 1 min at 94°C, 1 min at 65°C, and 2 min at 72°C. After the last cycle, a final extension step at 72°C for 10 min was done. 10 μl of each PCR reaction was dot blotted on a nylon filter (Hybond N^+^; Amersham Intl. Buckinghamshire, UK). Filters were prehybridized at 55°C for at least 2 h (6× SSC, 0.5% SDS, 5× Denhardt\'s, and 100 mg herring sperm DNA per liter), and hybridized overnight with an oligoprobe recognizing specifically the HPRT or RAG-1 PCR product internal to the PCR primers. Oligoprobes were ^32^P labeled according to the manufacturer\'s recommendations (Boehringer Mannheim). Sequences of the probe are as follows: 5′-GTCCCCTGTTGACTGGTCATTACAAT-3′ (HPRT probe), 5′-TCCTTTGAAAAGACACCTGAAGAAGC-3′ (RAG1 probe). To remove any nonspecifically bound probe, the filters were washed with excess amount of 2× SSC; 0.1% SDS at 50°C. Quantitation of the PCR products was done with a phosphoimager (Fujix Bas 2000; Fuji Photo Film Co., Ltd., Tokyo, Japan) and analyzed with the supplied software. Finally, the ratio of RAG-1/HPRT was calculated to compare the expression of the RAG-1 mRNA in the different samples.

Results
=======

Identification of Clonogenic CD4^+^CD8^+^ DP and CD4^+^ or CD8^+^ SP Thymocytes in the Human Thymus.
----------------------------------------------------------------------------------------------------

CD1a is a marker that is expressed on the great majority of DP thymocytes and part of the SP cells ([@B25]). Since this marker is not present on mature peripheral T cells, it is generally assumed that thymic emigrants are CD1a^−^, and that therefore, CD1a^+^ thymocytes are immature. Since a proportion of the SP cells is CD1a^+^, a linear model of differentiation predicts that virtually all DP cells would be CD1a^+^. A nonlinear differentiation model, however, would predict existence of CD1a^−^ cells among both DP and SP thymic populations. To examine this issue, we performed three parameter flow cytometric analysis of CD1a, CD4, and CD8, which confirmed earlier data that the vast majority of DP cells, and around 40% of the SP cells, express CD1a (Fig. [1](#F1){ref-type="fig"}). A very small percentage of the DP cells, however, is clearly negative for CD1a. Interestingly, the levels of CD4 and CD8 on the CD1a^−^ DP cells are lower than on total DP thymocytes (Fig. [1](#F1){ref-type="fig"}), suggesting that downregulation of either one of these coreceptors had already been initiated before completion of CD1a downregulation. To address whether the CD1a^−^ cells are functionally mature, we performed a limiting dilution of CD1a^−^ and CD1a^+^ cells. Table [1](#T1){ref-type="table"} shows that the cloning efficiencies of CD1a^−^ DP, CD4^+^, and CD8^+^ SP thymocytes in one representative experiment were 24, 41, and 34%, respectively. In sharp contrast, virtually none of the CD1a^+^ DP or CD1a^+^ SP cells could be cloned. The lack of clonogenic potential of CD1a^+^ subsets was not due to an inhibiting effect of the anti-CD1a antibody, since cloning efficiencies of unseparated SP cells plated in presence or absence of anti-CD1a mAb were virtually identical (results not shown). The in vitro expandable DP thymocytes could be cloned, and the majority of the DP clones maintained their DP phenotype for a prolonged period of time (results not shown) which is consistent with data published previously ([@B13], [@B14]). These data conclusively demonstrate that the clonogenic potential of SP and DP thymocytes resides exclusively in the CD1a^−^ subset, and that functional maturation, as defined by the ability to clonally expand, can already be manifested at the DP stage of thymocyte maturation.

Characterization of Immature CD1a^+^ SP Thymocytes.
---------------------------------------------------

The results of the limiting dilution experiments indicate that CD1a^+^CD3^high^ SP thymocytes are functionally immature. The observation that the great majority of the CD3^high^ cells in the thymus express the activation marker CD69, which is induced after positive selection ([@B26]--[@B28]) suggests, however, that positive selection signals have been delivered to a significant proportion of the CD1a^+^ SP cells. To further substantiate whether the CD1a^+^ SP cells have been submitted to selection signals, we investigated not only expression of CD69, but also Bcl-2 which is associated with positive selection as well ([@B29], [@B30]). In addition, expression of CD27 was analyzed. CD27 is expressed on most CD3^high^ human thymocytes, and may also be associated with positive selection ([@B31]). Three parameter analysis of CD1a^+^ SP cells confirms that the majority of these cells express CD69, Bcl-2, and CD27 (Table [2](#T2){ref-type="table"}). These data are consistent with expression profiles of CD69 ([@B25]), Bcl-2 ([@B32]), and CD27 ([@B31]) on total human CD3^high^ thymocytes published previously. Besides upregulation of CD69, positive selection also results in downregulation of RAG-1 ([@B28], [@B33]). A semi-quantitative reverse transcriptase-PCR of the CD1a^+^ and CD1a^−^ SP populations revealed that CD8^+^CD1a^+^ cells still express levels of RAG-1 which are comparable to that of total thymocytes (Fig. [2](#F2){ref-type="fig"} *A*). The levels of RAG mRNA in CD1a^+^ CD4^+^ SP cells, however, are much lower than that of total cells (Fig. [2](#F2){ref-type="fig"} *B*). Taken together, these data can be interpreted to indicate that CD1a^+^ SP cells express some, but not all, features of cells that have received a TCR-mediated positive selection signal.

Development of Human CD4^+^ SP Cells in a Mouse Fetal Thymus Requires Mouse MHC Class II Antigens, but the Mouse Thymus Is Inefficient at Inducing Maturation of Human CD4^+^ SP T Cells.
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Recently it was demonstrated that human progenitor cells can develop in mouse thymic organs in a FTOC ([@B18], [@B34]--[@B37]). Human progenitor cells developed into SP cells, but human stromal cells were not detectable in such cultures ([@B36]). Human CD4 can replace mouse CD4 in development of mouse MHC class II--restricted T cells ([@B38]). To address the question of whether interaction of human CD4 with mouse MHC class II can select human CD4^+^ T cells, FTOC were performed with thymi from MHC class II--positive and MHC class II--deficient mice. The mouse thymi were reconstituted with CD34^+^CD1a^−^ postnatal thymocytes that include the most primitive thymic T cell precursors ([@B39], [@B40]). After incubation in a MHC class II--positive murine thymic microenvironment, 6.5% of the harvested cells were TCR αβ^+^ CD4^+^ SP (Fig. [3](#F3){ref-type="fig"} *A*). By contrast, the number of TCRαβ^+^CD4^+^ SP T cells recovered from thymi of MHC class II--deficient mice was reduced considerably to 0.46% in experiment 1 (Fig. [3](#F3){ref-type="fig"} *B*) and 0.05% in experiment 2 (Fig. [3](#F3){ref-type="fig"} *C*), compared to that recovered from thymi of MHC class II--positive mice (6--10% in four independent experiments). A significant portion of the TCRαβ^+^ cells that developed in a class II MHC--positive thymic environment expressed CD69 (Fig. [3](#F3){ref-type="fig"} *D*), indicating that some cells were activated, presumably as a consequence of selection via the TCR. These findings indicate that mouse MHC class II antigens can positively select human CD4^+^ cells. It is noteworthy that very few human CD8^+^TCRαβ^+^ SP cells could be recovered from the FTOC with human CD34^+^CD1a^−^ cells and the mouse thymi. There were more CD3^+^CD8^+^ SP cells present and \>90% of those cells express TCR γδ (results not shown). One possible reason for this is that mouse MHC class I does not efficiently select human CD8^+^ T cells, despite the fact that human CD8 is able to functionally interact with the α3 domain of mouse H2Kb ([@B41]). Another explanation is that in addition to class I MHC, other signals are required for selection of CD8^+^ T cells.

Having established that MHC class II antigens can support development of human CD4^+^ SP T cells, we next investigated whether the mouse thymic environment can induce downregulation of CD1a and functional maturation. Early thymic CD34^+^CD1a^−^ progenitors were isolated and cultured in FTOC for 4 wk. Analysis of the cells harvested from the FTOC revealed the presence of TCR αβ and TCR γδ^high^ cells. Almost all TCR αβ^high^ cells expressed CD1a, while most TCR γδ^high^ cells lacked CD1a (Fig. [4](#F4){ref-type="fig"}). Immature TCR γδ^dim^ cells mostly expressed CD1a (Fig. [4](#F4){ref-type="fig"}). Stimulation of the cells harvested from the FTOC with a feeder cell mixture, PHA, and IL-2 resulted in expansion mostly of TCR γδ^+^ cells and few TCR αβ^+^ cells (Fig. [5](#F5){ref-type="fig"}). Most of those TCR αβ^+^ cells that were expanded expressed CD4 (Fig. [5](#F5){ref-type="fig"}). These data demonstrate that although the mouse MHC class II--positive mouse thymic environment can support development of CD4^+^ SP thymocytes, it is very inefficient in induction of functional maturation of these cells. By contrast, the mouse thymic microenvironment efficiently induces maturation of TCR γδ^+^ cells. Thus, failure of the mouse MHC class II--positive environment to induce functional maturation of TCR αβ^+^ cells is not due to a intrinsic incapability to support maturation of human T cells.

Differentiation of CD1a^+^ to CD1a^−^ CD4^+^ SP Cells.
------------------------------------------------------

The presence of CD1a^+^ and CD1a^−^ SP thymocytes raises the question whether CD1a^+^ SP cells are the direct precursors of CD1a^−^ SP cells. An alternative possibility would be that the CD1a^−^ SP cells are derived from the CD1a^−^ DP cells and that CD1a^+^ SP cells represent a dead-end lineage. To investigate this, we cocultured purified CD1a^+^CD4^+^ SP cells with short term cultured human thymic stromal cells. This coculture resulted in a gradual downregulation of CD1a which was completed on day 12 (Fig. [6](#F6){ref-type="fig"} *A*). Phenotypic analysis of these cells reveals that they express high levels of TCR αβ and CD4. Unexpectedly, many of these cells also express CD8α (Fig. [6](#F6){ref-type="fig"} *B*). These differentiated CD1a^−^ cells could be expanded in vitro and the phenotype did not alter upon expansion (Fig. [6](#F6){ref-type="fig"} *B*). These data indicate that CD1a^+^ CD4^+^ SP cells can differentiate to expandable CD1a^−^CD4^+^ SP cells and also to expandable CD1a^−^ CD4^+^CD8α^+^ cells.

Presence of DP Cells in Neonatal Cord Blood.
--------------------------------------------

As indicated in Fig. [1](#F1){ref-type="fig"}, the thymus contains expandable CD1a DP cells. Although not shown here, we were able to clone DP cells and these clones maintained a persistent DP phenotype upon long-term culture in accord with data published ([@B13], [@B14]). The presence of DP cells, expressing several characteristics of maturity, raises the question whether these cells are able to migrate from the thymus. DP cells could be observed in T cell samples from neonatal cord blood (Fig. [7](#F7){ref-type="fig"}) in percentages ranging from 0.5 to 3% of the total number of CD3^+^ T cells (*n* = 4). All DP cord blood cells express CD3 and CD27, and they lack CD1a or the activation antigen CD69 (Fig. [7](#F7){ref-type="fig"}). Further analysis of these cells indicate that the majority of these cells express CD45RA, and are negative for CD45RO and Fas (Fig. [7](#F7){ref-type="fig"}) suggesting that these DP cells represent naive, not memory, cells. Moreover, like in the thymus ([@B42]), both CD8α^+^β^−^CD4^+^ and CD4^+^CD8α^+^β^+^ cells could be observed. These observations are compatible with the notion that DP cells can migrate out of the thymus.

Discussion
==========

In this paper we have investigated acquisition of functional maturity by human thymocytes. The hypothesis that forms the basis of this study is that maturity of  T cells is appropriately and faithfully reflected by their capacity to expand in vitro. We think that this is the case because in vitro expandability is a general property of mature peripheral T cells. Moreover, T cell clones derived from mature thymocytes can mediate cytotoxic activities and produce cytokines upon stimulation in vitro (data not shown). Accepting our premise, the data argue that some DP are mature, while a considerable proportion of the SP cells in the human thymus are functionally immature. Most importantly, acquisition of functional maturity correlates with downregulation of CD1a. The cognizance that CD1a marks immature cells within thymocyte subpopulations allowed a meaningful and detailed analysis of these cells and a comparison with functionally mature thymocytes.

Our findings that CD1a^+^ SP cells are not clonogenic in vitro confirm and extend findings of Vanhecke et al. who investigated the clonogenic potential of CD4^+^ SP human thymocyte subsets ([@B42]). The CD1a^+^CD4^+^ SP thymocytes acquire the capacity to expand in vitro after cocultivation with short term cultured thymic stromal cells. This acquisition paralleled downregulation of CD1a. The observations identifying functionally immature CD1a^+^CD4^+^ SP cells are compatible with recent findings in the mouse by Dyall et al. ([@B12]) who demonstrated that a proportion of CD4^+^ SP murine thymocytes are functionally immature by several criteria. In many respects, the immature CD1a^+^CD3^+^ CD4^+^ SP thymocytes in the human thymus are similar to the functionally immature CD3^+^CD4^+^ SP in the mouse thymus ([@B12]). The immature mouse CD4^+^ SP thymocytes can be distinguished from mature cells by virtue of their expression of CD24 and high levels of CD69 ([@B12]). CD8 was not detectable by fluorimetric analysis, but the fact that the immature CD4^+^ SP mouse cells can be retained on antiCD8 immobilized on plastic indicates that low levels of CD8 are present on the immature CD4^+^ SP cells ([@B12]). Similar to the immature CD3^+^CD4^+^ SP population in the mouse, the human CD1a^+^CD4^+^ cells express CD69 and Bcl-2, indicative for cells that have been submitted to a positive selection signal ([@B26]--[@B30]). In addition, most CD1a^+^CD4^+^ SP cells express CD27, which may be another marker that is induced by positive selection ([@B31], [@B42], [@B43]). Human CD1a^+^CD3^+^ CD4^+^ SP cells expressed RAG-1, though in lower levels than total thymocytes. However, our inability to analyse RAG expression in individual cells precludes consideration of the possibility that a proportion of CD4^+^ CD1a^+^ SP cells are negative for RAG-1. Also, the CD8^+^ SP population in the human thymus contains functionally immature CD1a^+^ cells. The observation that heat stable antigen^+^CD8^+^ SP cells are present in the mouse thymus ([@B10]) suggested that there are immature cells also within the CD8^+^ SP thymic population, but the functional activity of those cells was not tested. The immature human CD1a^+^ CD8^+^ SP cells are similar to the CD1a^+^CD4^+^ SP cells in that the majority expresses CD69, Bcl-2, and CD27, but differ in expression levels of RAG-1, which are much higher than on CD1a^+^ CD4^+^ SP cells.

Although the expression of CD27, CD69, Bcl-2, and high levels of CD3 on part of the immature CD1a^+^ DP and almost all CD1a^+^ SP thymocytes indicates that these CD1a^+^ cells have been submitted to a positive selection signal, it is clear that a transition to CD1a^−^ cells is required to confer functional maturity to these thymocytes. Two possible mechanisms for the discrepancy between upregulation of CD27, CD69, and Bcl-2, and the CD1a^+^ to CD1a^−^ switch can be put forward. One is that downregulation of CD1a and acquisition of functional competence requires a much greater sustained MHC/TCR interaction than induction of CD69. This idea would take into consideration data from mouse studies indicating that consecutive, or perhaps even continual, TCR/MHC interactions are required to complete positive selection ([@B44]--[@B46]). A second possibility is that MHC/TCR interactions are sufficient for upregulation of CD69, but that an additional signal is required for downregulation of CD1a and acquisition of functional maturity. Our experiments with the hybrid human/mouse FTOC system provides support for the notion that two signals are required for induction of the functional program in immature thymocytes. We observed that although interactions of mouse MHC class II antigens with human CD4 and TCR drive generation of CD4^+^ SP cells, the mouse thymic microenvironment is very inefficient in downregulating CD1a and inducing functional maturation of CD4^+^ TCR αβ T cells. The inefficiency of mouse thymic microenvironment to induce functional maturity in CD4^+^ TCRαβ^+^ T cells is not due to, for example, tissue culture conditions since TCR γδ cells mature efficiently in the mouse FTOC. Moreover, we observed that cocultivation of CD1a^+^ CD4^+^ SP cells with human thymic stromal cells results in differentiation to CD1a^−^ cells. Taken together, these observations raise the possibility that species-specific activating or costimulatory molecules are required for efficient maturation of human CD4^+^ T cells.

In this paper, we confirm and extend earlier findings ([@B13], [@B14]) that the human thymus contains in vitro expandable DP cells. In vitro expandable DP thymocytes have also been found in the mouse ([@B15]). In vitro expandability of human DP thymocytes correlates perfectly with completion of downregulation of CD1a, as was also the case for SP cells. Our observations that DP cells are present in the periphery of neonates suggest that some mature CD1a^−^ DP cells may migrate out of the thymus. Most of these peripheral DP cells have characteristics of naive cells in that they express CD45RA and are negative for CD45RO and Fas, which are selectively expressed on memory cells. As was also found within the mature DP thymocytes, cord blood DP T cells lack CD1a and a proportion lacks CD8β as well. The characteristics of these DP cord blood cells make it unlikely that they are derived from peripheral SP cells that have upregulated CD4 or CD8 due to activation. It seems, therefore, that the CD4CD8 phenotype becomes stable once the DP cells have been submitted to a maturation signal. The fact that cloned lines of DP thymocytes with sustained CD4CD8 phenotype can be established is consistent with this notion. It is relevant to note that cloned lines of DP T cells have been established from peripheral T cells ([@B47]). It is possible that those clones originated from cells that emigrated from the thymus as DP cells.

The presence of both mature clonogenic DP cells and immature SP cells is difficult to reconcile with a generalized linear model of thymocyte differentiation from immature TCRαβ^+^CD4^+^CD8^+^ DP cells via immature to mature SP cells. It is possible that for some thymocytes, completion of positive selection and acquisition of functional competence can occur at the DP stage, while for others this could happen at the SP stage. However, at least part of the CD1a^−^ DP cells could be derived not from CD1a^+^ DP cells but from CD1a^+^CD4^+^ SP cells. This is suggested by the experiments in which CD1a^+^CD4^+^ SP thymocytes were cocultured with short term cultures of postnatal stromal cells. The cells harvested from such cocultures lacked CD1a and expressed CD3 and CD4, but a large proportion of these cells coexpress CD8α. This phenotype persisted after expansion of these cells. It is also possible that some of the CD1a^−^ DP cells are derived from CD1a^−^ SP cells as suggested by the experiments depicted in Fig. [6](#F6){ref-type="fig"}. Finally, we have considered the possibility that the CD1a^−^ DP cells are derived from cells that never expressed CD1. This cannot be excluded; however, we consider this unlikely since virtually all CD3^−^CD4^+^ immature SP cells considered to be the precursors of the DP cells, express CD1a ([@B39]). Further experiments are needed to elucidate the differentiation patterns of thymocytes after being submitted to positive selection mediated by the MHC/TCR interaction.
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^1^ *Abbreviations used in this paper:* DP, double positive; FTOC, fetal thymic organ culture; HPRT, hypoxanthine phosphoribosyl transferase; RAG, recombination activating gene; SP, single positive; TRC, TriColor.

![Expression of CD1a on CD4^+^CD8^+^DP, CD4^+^SP, and CD8^+^SP postnatal thymocyte populations. Total postnatal thymocytes were stained with CD1a FITC, CD8 PE, and CD4 TRC. The dot plots show the pattern of CD4 against CD8 staining of total thymocytes gated on CD1a^−^ (*R1*) and CD1a^+^ (*R2*) thymocytes.](JEM.res1){#F1}

###### 

Plating Efficiencies of Subsets of CD1a^+^ and CD1a^−^ Thymocytes

  Thymocytes       Number of positive wells                        
  ------------- -- -------------------------- -- -------------- -- --------------
  Exp. 1                                                           
  CD1^+^DP          0/144                         0/24              0/12
  CD1^−^DP         34/144 (24%)                  15/24 (63%)       12/12 (100%)
  CD1^+^CD4SP       1/144 (1%)                    0/24              0/12
  CD1^−^CD4SP      59/144 (41%)                  23/24 (96%)       12/12 (100%)
  CD1^+^CD8SP       0/144                         0/24              1/12 (8%)
  CD1^−^CD8SP      49/144 (34%)                  24/24 (100%)      12/12 (100%)
  Exp. 2                                                           
  CD1^+^CD4SP       0/60                          0/24             NT
  CD1^−^CD4SP      15/60 (25%)                   22/24 (92%)        6/6 (100%)
  CD1^+^CD8SP       0/60                          0/24              0/6
  CD1^−^CD8SP      16/60 (27%)                   20/24 (83%)        6/6 (100%)

###### 

Expression of CD27, CD69, and Bcl-2 on CD1a^+^ versus CD1a^−^ CD4 and CD8 SP Postnatal Thymocytes

                            Percentage of thymocytes expressing               
  ---------- -- -------- -- ------------------------------------- -- ----- -- -----
                            *%*                                      *%*      *%*
  CD3CD4SP      CD1^+^       62                                       95       99
                CD1^−^      100                                       67      100
  CD3CD8SP      CD1^+^       88                                      100       96
                CD1^−^      100                                       72      100

Thymocytes were stained with CD4TRC/CD8PE or CD8TRC/CD4 PE and FACStar^®^ sorted for TRC^+^PE^−^ CD4 and CD8 SP cells. Sorted cells were stained with CD27 FITC, CD69 FITC, Bcl-2 FITC, and CD3 FITC against CD1a PE or with control antibodies. The percentages of CD1 positive and negative cells CD4 and CD8 SP thymocytes that express the above markers were determined by FACScan^®^ analysis. The indicated percentages are those on CD3^high^SP cells.  

###### 

RAG-1 expression of total unseparated thymocytes and CD1a^−^ and CD1a^+^ CD8 (*A*) and CD4 SP (*B*) postnatal thymocytes. Thymocytes were depleted with magnetic beads for \>97% of CD4 or CD8 positive cells. CD4^−^ cells were labeled with CD8 FITC, CD1a PE, and CD3 TRC and sorted from CD1a^+^ and CD1a^−^ CD3^+^CD8^+^ SP cells (*A*). Likewise, CD1a^+^ and CD1a^−^ CD4^+^ SP cells were sorted from CD8^−^ cells stained with CD4 FITC, CD1a PE, and CD3 TRC (*B*).
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###### 

Multiparameter analysis of cells harvested from one FTOC with thymi of MHC class II--positive mice (*A* and *D*) and two FTOC with MHC class II--deficient mice (*B* and *C*). FTOC were set up as indicated in Materials and Methods with 25,000 CD34^+^CD1a^−^ postnatal thymocytes per lobe and incubated for 4 wk. Cell numbers harvested from the FTOC cultures were 150,000 cells per lobe in the culture with MHC class II--positive thymic lobes (*A* and *D*), and 175,000 (*B*) and 100,000 cells (*C*) per lobe in the cultures with MHC class II--negative thymic lobes. Cells harvested from the FTOC cultures were stained for threecolor analysis with CD4 FITC, TCR αβ PE, and CD8 TRC. Human cells were gated on the basis of forward and side scatter profile; all cells within this gate were positive for human CD45. CD4 against CD8 staining is indicated as dot plots. The histograms show the expression of TCR αβ on the CD4^+^CD8^−^ and CD8^+^CD4^−^ thymocytes. Numbers in histograms represent the percentages of CD4^+^ or CD8^+^ TCR αβ^+^ SP cells in the total population of human cells derived from the FTOC.
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![CD1a expression on CD3^+^TCR αβ^+^ and CD3^+^TCR αβ^−^ (TCR γδ^+^) cells, harvested from an FTOC incubated for 4 wk with CD34^+^CD1a^−^ postnatal thymocytes. FTOC-derived cells were stained with CD1a FITC, TCR αβ PE, and CD3 TRC. The dot plot demonstrates the pattern of TCR αβ PE versus CD3 TRC staining. The histograms indicate CD1a FITC expression of the CD3^high^ cells that express TCR αβ, and the CD3^int^ and CD3^high^ TCR αβ^−^ cells which represent the immature and mature γδ T cells, respectively.](JEM.res4){#F4}

![Phenotype of T cells expanded from the FTOC (the same one as indicated in Fig. [4](#F4){ref-type="fig"}) with a feeder cell mixture, PHA, and IL-2. Expanded cells were stained with TRC γδ FITC and TCR αβ PE or with CD4 FITC, TCR αβ PE, and CD8 TRC. The dot plots show the expression of TCR γδ versus TCR αβ of all cells and the expression of CD4 against CD8 of gated TCR αβ^+^ cells.](JEM.res5){#F5}

###### 

CD1a^+^CD4^+^ SP thymocytes differentiate into CD1a^−^ cells upon coculture with thymic stromal cells (*A*), and part of these cells upregulate CD8 expression (*B*). Thymocytes were labeled with CD1a FITC, CD4 PE, and CD8 TRC. CD1a^+^ and CD1a^−^ CD4^high^ SP cells were sorted and part of the cells were used to check CD3 expression by staining with CD3 TRC (all CD1a^−^ and \>99% of CD1^+^ CD4 SP thymocytes were CD3^+^). In experiment A, 2 × 10^5^ CD1a^+^CD4 SP (\>98% purified) and 2 × 10^5^ CD1a^−^CD4 SP cells were cultured on a monolayer of human thymic stromal cells. After 4 and 12 d, cells were tested for CD1a expression. The cell numbers of wells started with CD1a^+^ and CD1a^−^CD4 SP cells were both reduced to 8 × 10^4^ after 4 d, whereas at day 12, 2.5 × 10^4^, and 7.0 × 10^4^ (CD1a^−^) cells were recovered from the cultures started with CD1a^+^ and CD1a^−^CD4 SP thymocytes, respectively. In experiment B, sorted CD1a^+^ and CD1a^−^ CD4 SP thymocytes were cultured for 7 d on a monolayer of thymic stromal cells, assayed for CD4 and CD8 expression, and expanded in vitro with feeder cells, PHA, and IL-2. Expanded cells were also analysed for CD4 against CD8 expression.

![](JEM.res6a)

![](JEM.res6b)

![Three parameter analysis of neonatal cord blood cells. Cord blood lymphocytes were obtained by centrifugation over Lymphoprep (Nycomed Pharma, Oslo, Norway). Monocytes/macrophages and contaminating erythrocytes were depleted with goat anti--mouse IgG coated magnetic beads (Dynal Inc.) using monoclonal antibodies against CD14 and glycophorin. The remaining cells were stained with CD4 PE and CD8 TRC against the indicated FITC conjugated antibodies.](JEM.res7){#F7}

[^1]: Address correspondence to Hergen Spits, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
